BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10371350)

  • 1. Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer.
    Hefler L; Obermair A; Tempfer C; van Houte M; Maenner G; Reinthaller A; Leodolter S; Kainz C
    Int J Cancer; 1999 Jun; 84(3):299-303. PubMed ID: 10371350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.
    Hefler L; Frischmuth K; Heinze G; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Tempfer C
    Int J Cancer; 1999 Oct; 83(2):167-70. PubMed ID: 10471522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
    Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P
    Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of tissue polypeptide antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer.
    Hefler L; Tempfer C; Frischmuth K; Maenner G; Concin N; Sliutz G; Reinthaller A; Leodolter S; Kainz C
    Tumour Biol; 2000; 21(2):98-104. PubMed ID: 10686539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
    Hefler L; Tempfer C; Obermair A; Frischmuth K; Sliutz G; Reinthaller A; Leodolter S; Kainz C
    Clin Cancer Res; 1999 Oct; 5(10):2806-9. PubMed ID: 10537345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
    J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
    PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
    Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of re-excision of residual adjacent vulvar intraepithelial neoplasia (VIN III) and histological tumour-free margin (hTFM) on survival in primary squamous cell carcinoma of vulva.
    Gasimli K; Straussner M; Schmeil I; Karn T; Winkelmann R; Becker S; El-Balat A
    Arch Gynecol Obstet; 2018 Nov; 298(5):945-950. PubMed ID: 30187190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
    Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pretreatment SUV
    Shou H; Yasuo Y; Yuan S; Lou H; Ni J
    Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
    Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
    Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.
    Molina R; Torres MD; Moragas M; Perez-Villa J; Filella X; Jo J; Farrus B; Giménez N; Traserra J; Ballesta AM
    Tumour Biol; 1996; 17(2):81-9. PubMed ID: 8658017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
    Salvatici M; Achilarre MT; Sandri MT; Boveri S; Vanna Z; Landoni F
    Gynecol Oncol; 2016 Jul; 142(1):115-119. PubMed ID: 27117922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
    Strauss HG; Laban C; Lautenschläger C; Buchmann J; Schneider I; Koelbl H
    Eur J Cancer; 2002 Oct; 38(15):1987-91. PubMed ID: 12376202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
    Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
    Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of squamous cell carcinoma antigen as a predictor of inguinofemoral lymph node metastasis in patients with vulvar cancer.
    Nather A; Sami A; Hefler L; Leodolter S; Joura EA
    J Reprod Med; 2002 Sep; 47(9):718-20. PubMed ID: 12380452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.